Related Topics News -

     
 Title only   |   Print    Next page > 
     
博安生物度拉糖肽注射液完成在美國授權

2026-06-12T  
博安生物博洛加新適應症在中國獲批

2026-05-26T  
博安生物擬回購不超過2億元股份

2026-05-14T  
博安生物治療非小細胞肺癌藥物臨床試驗申請已獲受理

2026-04-27T  
《業績》博安生物全年純利714萬人民幣跌90.2% 不派息

2026-03-31T  
博安生物控股股東擬進一步轉讓1,198萬持股

2026-01-26T  
博安生物控股股東擬進一步轉讓3,850萬持股

2026-01-21T  
博安生物訂立融資租賃協議以補充營運資金

2026-01-15T  
博安生物成交量異常變動 控股股東上月發行可交換優先股

2026-01-12T  
博安生物阿柏西普眼內注射溶液在中國獲批上市

2025-11-26T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.